Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Monica Bertagnolli

Surgical Oncology · Harvard Medical School

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Porcine Xenotransplantation in End-Stage Kidney Disease

    Sep 4, 2025DOI: 10.1056/nejmc2508235CorrespondenceNEJM

    Summary

    To the Editor: Kawai et al. (May 15 issue) report a gene-edited porcine kidney xenograft in a human participant who survived for 52 days, an outcome that represents a landmark achievement in the field of xenotransplantation. Despite this progress toward improving the survival of xenografts, challenges remain. Although CD46 and CD55 expression probably mitigated complement-mediated injury in the patient described by Kawai et al., we propose a dual-targeting approach to further reduce xenograft rejection. First, CRISPR-mediated claudin-2 knockout (combined with CD46 and CD55 transgenes) might reduce membrane attack complex (MAC) deposition. Li et al. showed that claudin-2 promotes C5b-9 assembly . . .
    TKDr. Tatsuo Kawai

    Dr. Tatsuo Kawai

    Surgery · Kidney Transplantation
    Massachusetts General Hospital
    tatsuo